Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Intraindividual Variation in Markers of Intestinal Permeability and Adipose Tissue Inflammation in Healthy Normal-Weight to Obese Adults.

Kuzma JN, Hagman DK, Cromer G, Breymeyer KL, Roth CL, Foster-Schubert KE, Holte SE, Weigle DS, Kratz M.

Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):610-615. doi: 10.1158/1055-9965.EPI-18-0641. Epub 2018 Dec 20.

PMID:
30573517
2.

Consuming glucose-sweetened, not fructose-sweetened, beverages increases fasting insulin in healthy humans.

Kuzma JN, Cromer G, Hagman DK, Breymeyer KL, Roth CL, Foster-Schubert KE, Holte SE, Weigle DS, Kratz M.

Eur J Clin Nutr. 2019 Mar;73(3):487-490. doi: 10.1038/s41430-018-0297-5. Epub 2018 Aug 30.

3.

Stress Among Latinos: Does it Vary by Occupation and Agricultural Season?

Ulrich A, Molina Y, Briant KJ, Onstad LE, Copeland W, Holte SE, Thompson B.

J Occup Environ Med. 2018 Sep;60(9):810-814. doi: 10.1097/JOM.0000000000001333.

PMID:
29634611
4.

Symmetric Directional False Discovery Rate Control.

Holte SE, Lee EK, Mei Y.

Stat Methodol. 2016 Dec;33:71-82. doi: 10.1016/j.stamet.2016.08.002. Epub 2016 Aug 24.

5.

Results of a randomized controlled trial to increase cervical cancer screening among rural Latinas.

Thompson B, Carosso EA, Jhingan E, Wang L, Holte SE, Byrd TL, Benavides MC, Lopez C, Martinez-Gutierrez J, Ibarra G, Gonzalez VJ, Gonzalez NE, Duggan CR.

Cancer. 2017 Feb 15;123(4):666-674. doi: 10.1002/cncr.30399. Epub 2016 Oct 27.

6.

No differential effect of beverages sweetened with fructose, high-fructose corn syrup, or glucose on systemic or adipose tissue inflammation in normal-weight to obese adults: a randomized controlled trial.

Kuzma JN, Cromer G, Hagman DK, Breymeyer KL, Roth CL, Foster-Schubert KE, Holte SE, Weigle DS, Kratz M.

Am J Clin Nutr. 2016 Aug;104(2):306-14. doi: 10.3945/ajcn.115.129650. Epub 2016 Jun 29.

7.

Epidemiology and Health-Related Quality of Life in Hypoparathyroidism in Norway.

Astor MC, Løvås K, Debowska A, Eriksen EF, Evang JA, Fossum C, Fougner KJ, Holte SE, Lima K, Moe RB, Myhre AG, Kemp EH, Nedrebø BG, Svartberg J, Husebye ES.

J Clin Endocrinol Metab. 2016 Aug;101(8):3045-53. doi: 10.1210/jc.2016-1477. Epub 2016 May 17.

8.

A Pilot Study of Raltegravir Plus Combination Antiretroviral Therapy in Early Human Immunodeficiency Virus Infection: Challenges and Lessons Learned.

Collier AC, Chun TW, Maenza J, Coombs RW, Tapia K, Chang M, Stevens CE, Justement JS, Murray D, Stekler JD, Mullins JI, Holte SE.

Biores Open Access. 2016 Jan 1;5(1):15-21. doi: 10.1089/biores.2015.0038. eCollection 2016.

9.

No difference in ad libitum energy intake in healthy men and women consuming beverages sweetened with fructose, glucose, or high-fructose corn syrup: a randomized trial.

Kuzma JN, Cromer G, Hagman DK, Breymeyer KL, Roth CL, Foster-Schubert KE, Holte SE, Callahan HS, Weigle DS, Kratz M.

Am J Clin Nutr. 2015 Dec;102(6):1373-80. doi: 10.3945/ajcn.115.116368. Epub 2015 Nov 4.

10.

HIV-1 shedding from the female genital tract is associated with increased Th1 cytokines/chemokines that maintain tissue homeostasis and proportions of CD8+FOXP3+ T cells.

Bull ME, Legard J, Tapia K, Sorensen B, Cohn SE, Garcia R, Holte SE, Coombs RW, Hitti JE.

J Acquir Immune Defic Syndr. 2014 Dec 1;67(4):357-64. doi: 10.1097/QAI.0000000000000336.

11.

Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection.

Raj DK, Nixon CP, Nixon CE, Dvorin JD, DiPetrillo CG, Pond-Tor S, Wu HW, Jolly G, Pischel L, Lu A, Michelow IC, Cheng L, Conteh S, McDonald EA, Absalon S, Holte SE, Friedman JF, Fried M, Duffy PE, Kurtis JD.

Science. 2014 May 23;344(6186):871-7. doi: 10.1126/science.1254417.

12.

Human immunodeficiency viruses appear compartmentalized to the female genital tract in cross-sectional analyses but genital lineages do not persist over time.

Bull ME, Heath LM, McKernan-Mullin JL, Kraft KM, Acevedo L, Hitti JE, Cohn SE, Tapia KA, Holte SE, Dragavon JA, Coombs RW, Mullins JI, Frenkel LM.

J Infect Dis. 2013 Apr 15;207(8):1206-15. doi: 10.1093/infdis/jit016. Epub 2013 Jan 11.

13.

HIV-1 RNA may decline more slowly in semen than in blood following initiation of efavirenz-based antiretroviral therapy.

Graham SM, Holte SE, Dragavon JA, Ramko KM, Mandaliya KN, McClelland RS, Peshu NM, Sanders EJ, Krieger JN, Coombs RW.

PLoS One. 2012;7(8):e43086. doi: 10.1371/journal.pone.0043086. Epub 2012 Aug 13.

14.

Do workplace and home protective practices protect farm workers? Findings from the "For Healthy Kids" study.

Coronado GD, Holte SE, Vigoren EM, Griffith WC, Barr DB, Faustman EM, Thompson B.

J Occup Environ Med. 2012 Sep;54(9):1163-9.

15.

Efficient use of longitudinal CD4 counts and viral load measures in survival analysis.

Holte SE, Randolph TW, Ding J, Tien J, McClelland RS, Baeten JM, Overbaugh J.

Stat Med. 2012 Aug 30;31(19):2086-97. doi: 10.1002/sim.5318. Epub 2012 Mar 13.

16.

Post-prostatic massage fluid/urine as an alternative to semen for studying male genitourinary HIV-1 shedding.

Graham SM, Krieger JN, Githua PL, Wamuyu LW, Wale S, Ramko KM, Dragavon JA, Muller CH, Holte SE, Mandaliya KN, McClelland RS, Peshu NM, Sanders EJ, Coombs RW.

Sex Transm Infect. 2011 Apr;87(3):232-7. doi: 10.1136/sti.2010.047118. Epub 2011 Jan 29.

17.

[A cold, confused and edematous 56-year old man].

Jortveit J, Gundersen T, Holte SE, Brunvand H.

Tidsskr Nor Laegeforen. 2008 Feb 28;128(5):572-3. Norwegian. No abstract available.

PMID:
18333288
18.

The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals.

Tegger MK, Crane HM, Tapia KA, Uldall KK, Holte SE, Kitahata MM.

AIDS Patient Care STDS. 2008 Mar;22(3):233-43. doi: 10.1089/apc.2007.0092.

PMID:
18290749
19.

Sentinel surveillance of sexually transmitted infections/HIV and risk behaviors in vulnerable populations in 5 Central American countries.

Soto RJ, Ghee AE, Nunez CA, Mayorga R, Tapia KA, Astete SG, Hughes JP, Buffardi AL, Holte SE, Holmes KK; Estudio Multicentrico Study Team.

J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):101-11.

PMID:
17972366
20.

A comparison of methods for determining HIV viral set point.

Mei Y, Wang L, Holte SE.

Stat Med. 2008 Jan 15;27(1):121-39.

PMID:
17787030
21.

Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding.

Graham SM, Holte SE, Peshu NM, Richardson BA, Panteleeff DD, Jaoko WG, Ndinya-Achola JO, Mandaliya KN, Overbaugh JM, McClelland RS.

AIDS. 2007 Feb 19;21(4):501-7.

PMID:
17301569
22.

Selection on the human immunodeficiency virus type 1 proteome following primary infection.

Liu Y, McNevin J, Cao J, Zhao H, Genowati I, Wong K, McLaughlin S, McSweyn MD, Diem K, Stevens CE, Maenza J, He H, Nickle DC, Shriner D, Holte SE, Collier AC, Corey L, McElrath MJ, Mullins JI.

J Virol. 2006 Oct;80(19):9519-29.

23.

Density-dependent decay in HIV-1 dynamics.

Holte SE, Melvin AJ, Mullins JI, Tobin NH, Frenkel LM.

J Acquir Immune Defic Syndr. 2006 Mar;41(3):266-76.

PMID:
16540927
24.

Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus.

Tobin NH, Learn GH, Holte SE, Wang Y, Melvin AJ, McKernan JL, Pawluk DM, Mohan KM, Lewis PF, Mullins JI, Frenkel LM.

J Virol. 2005 Aug;79(15):9625-34.

25.

Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation.

Buchbinder SP, Metch B, Holte SE, Scheer S, Coletti A, Vittinghoff E.

J Acquir Immune Defic Syndr. 2004 May 1;36(1):604-12.

PMID:
15097304
26.

Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy.

Frenkel LM, Wang Y, Learn GH, McKernan JL, Ellis GM, Mohan KM, Holte SE, De Vange SM, Pawluk DM, Melvin AJ, Lewis PF, Heath LM, Beck IA, Mahalanabis M, Naugler WE, Tobin NH, Mullins JI.

J Virol. 2003 May;77(10):5721-30.

27.

Incorporation of variability into the modeling of viral delays in HIV infection dynamics.

Banks HT, Bortz DM, Holte SE.

Math Biosci. 2003 May;183(1):63-91.

PMID:
12604136
28.

Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study.

Seage GR 3rd, Holte SE, Metzger D, Koblin BA, Gross M, Celum C, Marmor M, Woody G, Mayer KH, Stevens C, Judson FN, McKirnan D, Sheon A, Self S, Buchbinder SP.

Am J Epidemiol. 2001 Apr 1;153(7):619-27.

PMID:
11282787
29.

Anal sex among HIV-seronegative women at high risk of HIV exposure. The HIVNET Vaccine Preparedness Study 2 Protocol Team.

Gross M, Holte SE, Marmor M, Mwatha A, Koblin BA, Mayer KH.

J Acquir Immune Defic Syndr. 2000 Aug 1;24(4):393-8.

PMID:
11015157

Supplemental Content

Loading ...
Support Center